Chromatin immunoprecipitation (ChIP) assays showed that H101 treatment (MOI of 100) induced significant H3K4 trimethylation (me3) enrichment at the cGAS promoter (P1–P2) in SW620 (Fig. 6B) and LOVO tumor cells compared to the nontreated control (Fig. 6C). The gene discussed is CGAS; the disease is neoplasm.